fda approved semaglutide compound issues warning about some compounded versions of for diabetes, weight loss The End of Compounded Semaglutide:

For patients like Wysock, compounded versions of weight-loss medications have been life- changing

BMI 30 to 35 (class 1 obesity) This group typically sees strong responses to GLP-1 therapy

But a shift in mindset may just be what you need when dealing with a plateau

[1] [2] The precise mechanism in humans remains incompletely understood and is based partly on extrapolation from preclinical data and from clinical observations with approved GLP-1 receptor agonists

Do not warm Mounjaro or Wegovy in hot water, a microwave, direct sunlight, on a radiator, or in any other artificial heat source

Lauffer LM, Iakoubov R, Brubaker PL